New York - A new study released on Wednesday revealed that a high dose of the male hormone testosterone, improves the s.#.e.#.xual life of postmenopausal women after one year.
The testosterone patch Intrinsa is being developed by Procter & Gamble.
Before using the patches, women who participated in the study reported having s.#.e.#.xual acts typically about 2.5 per month.
The group of volunteers who received the highest dose of testosterone reported 2.1 episodes per month s.#.e.#.x, which implies a substantial increase compared with the placebo group who reported that on average less than one s.#.e.#.xual relationship per month.
The tests that measured the desire, orgasms, pleasure and personal image was two times greater in the group treated with high doses, the study said.
But the results, published in New England Journal of Medicine, showed that women who want to delay the biological clock when it comes to s.#.e.#.x would have to contend with an additional growth of hair. Four women involved in the study also developed breast cancer, although researchers contest that this finding was likely a chance occurrence.
“This is the first study to show that when used alone, testosterone administered by a skin patch significantly improves s.#.e.#.xual well-being in postmenopausal women,” the lead author, Dr. Susan R. Davis of Monash University in Prahran, Australia, said in a statement.
The testosterone patch is currently not available in the United States.
The study was funded with research grants from Procter & Gamble Pharmaceuticals, the manufacturer of the testosterone patch, Intrinsa.
The testosterone patch Intrinsa is being developed by Procter & Gamble.
Before using the patches, women who participated in the study reported having s.#.e.#.xual acts typically about 2.5 per month.
The group of volunteers who received the highest dose of testosterone reported 2.1 episodes per month s.#.e.#.x, which implies a substantial increase compared with the placebo group who reported that on average less than one s.#.e.#.xual relationship per month.
The tests that measured the desire, orgasms, pleasure and personal image was two times greater in the group treated with high doses, the study said.
But the results, published in New England Journal of Medicine, showed that women who want to delay the biological clock when it comes to s.#.e.#.x would have to contend with an additional growth of hair. Four women involved in the study also developed breast cancer, although researchers contest that this finding was likely a chance occurrence.
“This is the first study to show that when used alone, testosterone administered by a skin patch significantly improves s.#.e.#.xual well-being in postmenopausal women,” the lead author, Dr. Susan R. Davis of Monash University in Prahran, Australia, said in a statement.
The testosterone patch is currently not available in the United States.
The study was funded with research grants from Procter & Gamble Pharmaceuticals, the manufacturer of the testosterone patch, Intrinsa.
شرح موضوع